<DOC>
	<DOCNO>NCT00259883</DOCNO>
	<brief_summary>This study design assess efficacy safety combination therapy PAXIL benzodiazepine anxiolytic . PAXIL Tablet administer patient depression depressive episode receive Benzodiazepines least 4 week , change symptoms depression evaluate use rate extent decrease Hamilton Rating Scale Depression ( HAM-D ) .</brief_summary>
	<brief_title>Combination Of PAXIL Tablet And Benzodiazepines</brief_title>
	<detailed_description />
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Inclusion criterion : Patients depression depressive episode diagnose major depressive disorder accord DSMIV criterion . Patients 14 high point total score Items No.1 17 HAMD . Patients continuously receive Benzodiazepine anxiolytic . Exclusion criterion : Patients strong suicide tendency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>depressive episode</keyword>
	<keyword>paroxetine</keyword>
	<keyword>PAXIL</keyword>
	<keyword>depression</keyword>
	<keyword>benzodiazepine</keyword>
	<keyword>combination</keyword>
</DOC>